zoi piperigkou
Department of Chemistry, School of Science, University of Patras
Patras, Greece
Associate Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Associate Editors
ruth plummer
Newcastle University
Newcastle upon Tyne, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
jai prakash
University of Twente
Enschede, Netherlands
Associate Editor
Cancer Molecular Targets and Therapeutics
vivek m rangnekar
University of Kentucky
Lexington, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
annamaria rapisarda
Other
Frederick, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
francesca ricci
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
michel rigaud
Laboratory of Biosciences, Scientific Institute of Romagna for the Study and Treatment of Tumors (IRCCS)
Meldola, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
lori rink
Fox Chase Cancer Center
Philadelphia, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
tiago rodrigues
Federal University of ABC
Santo André, Brazil
Associate Editor
Cancer Molecular Targets and Therapeutics
rajesha rupaimoole
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
hatim e sabaawy
University of Colorado
Denver, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
stephen safe
Texas A and M University
College Station, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
ilyas sahin
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
kamal s saini
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
lucília ataíde saraiva
Faculty of Pharmacy, University of Porto
Porto, Portugal
Associate Editor
Cancer Molecular Targets and Therapeutics
giorgio seano
Institut Curie
Paris, France
Associate Editor
Cancer Molecular Targets and Therapeutics